연구성과로 돌아가기

2021 연구성과별 연구자 정보 (468 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Jang, Jae Young Jang, JY 5 Soonchunhyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Kweon, Young Oh Kweon, YO 6 Kyungpook Natl Univ, Dept Internal Med, Coll Med, Daegu, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Cho, Yong Kyun Cho, YK 7 Sungkyunkwan Univ, Dept Internal Med, Kangbuk Samsung Hosp, Sch Med, Seoul, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Kim, Yoon Jun Kim, YJ 8 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea J-2746-2012 Kim, Yoon umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Kim, Yoon Jun Kim, YJ 8 Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea J-2746-2012 Kim, Yoon umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Hong, Gun Young Hong, GY 9 Kwangju Christian Hosp, Dept Internal Med, Gwangju, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Kim, Dong Joon Kim, DJ 10 Hallym Univ, Dept Internal Med, Chunchon, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Kim, Dong Joon Kim, DJ 10 Hallym Univ, Ctr Liver & Digest Dis, Chunchon, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Jung, Young Kul Jung, YK 11 Korea Univ, Dept Internal Med, Coll Med, 73 Goryeodae Ro, Seoul 02841, South Korea 0000-0002-6566-1382 Jung, Young Kul umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Sohn, Joo Hyun Sohn, JH 12 Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Lee, Jin-Woo Lee, JW 13 Inha Univ, Dept Internal Med, Sch Med, Incheon, South Korea D-5883-2012 Lee, Shin-Jae umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Park, Sung Jae Park, SJ 14 Inje Univ, Paik Hosp, Dept Internal Med, Busan, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Lee, Byung Seok Lee, BS 15 Chungnam Natl Univ, Dept Gastroenterol & Hepatol, Sch Med, Daejeon, South Korea umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Kim, Ju Hyun Kim, JH 16 Gacheon Univ, Dept Internal Med, Coll Med, Incheon, South Korea K-7697-2013 Kim, Hyun umsh@korea.ac.kr;
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Kim, Hong Soo Kim, HS 17 Soonchunhyang Univ, Dept Internal Med, Coll Med, Cheonan, South Korea HQZ-0240-2023 Kim, Yong-Tae umsh@korea.ac.kr;
페이지 이동: